EC approves Vertex's Kaftrio + ivacaftor for cystic fibrosis in children aged 6 to 11 years
January 11 2022 - 5:14AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024